A Double‐blind Controlled Trial of a New α‐1 Blocking Drug in the Treatment of Bladder Outflow Obstruction

Abstract
Thirty-one patients with urodynamically proven bladder outflow obstruction were treated with Alfuzosin in a 3-month, double-blind, placebo-controlled study. The irritative symptoms of bladder outflow obstruction were improved significantly in the treatment group, according to both objective and subjective evaluation. There was no objective evidence of a reduction in outflow resistance or obstruction in either group.

This publication has 2 references indexed in Scilit: